Japan
UCB JAPAN COMPANY LTD. receives ESG Program of the Year - Japan at Healthcare Asia Pharma Awards 2025
UCB JAPAN COMPANY LTD. receives ESG Program of the Year - Japan at Healthcare Asia Pharma Awards 2025
The company bagged the accolade for its effective environmental, social, and governance activities through external collaboration.
2 days ago
Kaikoukai Healthcare Group brings home win at Healthcare Asia Awards 2025
It has ensured seamless support for its foreign patients through its multilingual support system, advanced medical treatments and training programmes.
2 days ago
Shonan Kamakura General Hospital honoured at Healthcare Asia Awards 2025
It was awarded as the Hospital of the Year - Japan for its dedication to delivering the highest standards of medical care to patients around the world.
2 days ago
Japan’s 10-year fund to boost pharmaceutical landscape
The country’s ageing population is driving demand for innovative treatments.
Japan’s medical device market to be valued at $42.9b by 2029
It is projected to surpass Germany to become the third-largest market globally.
NCC, PREMIA, Paradigm unveil nationwide clinical trial network in Japan
The LC-SCRUM-CD serves as an expansion of the LC-SCRUM-Asia network.
Japan’s diabetes device market to hit $2.8b by 2032
Its growth is attributed to technological advancements and developments.
Japan’s healthcare market projects stability amidst new leadership
Shigeru Ishiba was elected as president of the ruling LDP, succeeding Fumio Kishida on 27 September.
Here’s what’s driving Japan’s PCR systems market
The qPCR systems sector accounted for 53% of the APAC market in the current year.
Japan's haematology analysers market to rise at 5% CAGR through 2033
The sector accounted for around 70% of the APAC market in 2023.
NCGM and HMU ink five-year MoU on joint clinical research
The agreement is set to run until 2029.
Japan’s Juntendo Hospital develops technology for preventing patient falls
The tech was evaluated using data from about 70,000 of the hospital’s outpatients.
Japan's insulin pen market sees 3% CAGR growth
The country comprised a 28% market share of insulin pens in the Asia-Pacific.
Kurashiki Central Hospital names Akito Terai as new hospital and executive director
Sen Yamagata steps down from the role and assumes the role of general director.
Japan dental implants to reach $230m in 2033
Japan has accounted for over 12% of the dental implant market in APAC.
Private hospitals adopt more digital solutions vs public hospitals: report
Private hospitals prioritise digitisation for personalised patient information.
How hospitals in Japan procure medical resources: report
Public hospitals focus on quality care while private hospitals focus on efficiency.